Suchergebnisse - "Lu, Tianzhu"

PubPharm (3)

1

Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma

enthalten in: Radiation oncology (London, England) | 2022

von Lin, J. | Guo, Q. | Guo, Z. | +10

2

Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma

enthalten in: Radiation oncology | 2022

von Lin, J. | Guo, Q. | Guo, Z. | +10

3

Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma

enthalten in: Radiation oncology | 2022

von Lin, J. | Guo, Q. | Guo, Z. | +10

1
[1]